CRYSTALLINE FORMS OF 2-(4-(4-ETHOXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)-2-FLUOROPHENYL)-N-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)ACETAMIDE

Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin- 3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use...

Full description

Saved in:
Bibliographic Details
Main Authors EIDAM, HILARY SCHENCK, LAMEY, KIMBERLY ANNE, THOMAS, JAMES V, CHEUNG, MUI, CLARK, WILLIAM M
Format Patent
LanguageEnglish
French
Published 17.03.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin- 3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.
AbstractList Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin- 3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.
Author EIDAM, HILARY SCHENCK
LAMEY, KIMBERLY ANNE
CHEUNG, MUI
CLARK, WILLIAM M
THOMAS, JAMES V
Author_xml – fullname: EIDAM, HILARY SCHENCK
– fullname: LAMEY, KIMBERLY ANNE
– fullname: THOMAS, JAMES V
– fullname: CHEUNG, MUI
– fullname: CLARK, WILLIAM M
BookMark eNqNjM0KgzAQhD20h_69g0cLLtRf6DFoxEDMSkzB9CJS0lNRwT5KH7gR-wBlB5aZ-Zi9sxnGweycTyZ1owjnTFC3QFk1LhZuCF68iKoSWw0pYIsQ-CnkrNS5xFpLljMBEWh-hhAKfkObllQsXoCXgBf49kBJtpaWquyc5rUFibDWoqzBltyRr0Mko4pULKdHZ_vsX7M5_f7BcQuqshLMNHZmnvqHGcy7y0h4TS9xEpAg-gP5AlkAQTs
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FORMES CRISTALLINES DE 2-(4-(4-ETHOXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)-2-FLUOROPHENYL)-N-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)ACETAMIDE
ExternalDocumentID CA2960451A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2960451A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2960451A13
Notes Application Number: CA20152960451
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160317&DB=EPODOC&CC=CA&NR=2960451A1
ParticipantIDs epo_espacenet_CA2960451A1
PublicationCentury 2000
PublicationDate 20160317
PublicationDateYYYYMMDD 2016-03-17
PublicationDate_xml – month: 03
  year: 2016
  text: 20160317
  day: 17
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
RelatedCompanies_xml – name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Score 3.0248969
Snippet Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CRYSTALLINE FORMS OF 2-(4-(4-ETHOXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)-2-FLUOROPHENYL)-N-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)ACETAMIDE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160317&DB=EPODOC&locale=&CC=CA&NR=2960451A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMAwV9U2n4vyiDzImLNhuTbI-DOnSllbWZnSdtL6Mrquwl264iX_EH-yl-9AXJXnI5Y6DXLhcLsldELpXM5UZRsow7agE61lKsEFkIsg8VadsmlGmynhnP6DuSH-OSVxBs20sTJkn9LNMjggalYG-r8r1evFziGWVbyuXj5MZdM2fnKhr1TfecflnMqtbva49EJbgdc673KwHYbclk5AQzQRHaR920Uwqg_3Sk0Epi98WxTlBBwNgVqxOUSUvquiIbz9eq6JDf3PfDc2N6i3P0BcPk2Fkgu8d2Aq4bv5QEY7Swg1dVjtyRZxgikUssNak2PLcxArFIAk9ywtwGyf9B9zCTn8koNe1AwkHuEFwQ2tCwVHorZFA5QO7pD8AQjMAEEi9oYjNV9FfMzK5HZm-Z9nnSHHsiLsYhjfeiXLMzZ0g2hdor5gX-SVSGElpO88zSlOi50w3pqn-puuZRnNi0E5aQ7U_2Vz9g7tGx3JO5JMtjd2gvdX7R34LNnw1uSul_w02xpOC
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMAwV9U2n4vzsg4wJC7Zbk6wPQ7q0pdW2GV0nrS-j6yrsZYqb-Ef8wV66D31RkofcBwe5cEkuyV0QulFzlRlGxjDtqATreUawQWQiyCJTJ2ySU6bKeOcgpO5Qf0hIUkHTdSxMmSf0s0yOCBaVg70vyvn67ecQyyrfVs7vxlNAvd47cdeqr7zj8s9kVrd6XbsvLMHrnHe5WQ-jbksmISGaCY7SNuywmTQG-6kng1Lefq8ozgHa6YOw2eIQVYpZFe3x9cdrVbQbrO67obkyvfkR-uJROohN8L1DWwHXLRgowlFauKHLaseuSFJMsUgE1poUW56bWpHop5FneSFu49S_xS3s-EMBWNcOJRziBsENrQkFx5G3JAJXAOJSvw-MZgggsHoDkZjPwl8KMrkdm4Fn2cdIceyYuxi6N9qocsTNjSLaJ2hr9jorTpHCSEbbRZFTmhG9YLoxyfQXXc81WhCDdrIaqv0p5uwf2jXac-PAH4FmHs_Rvhwf-XxLYxdoa_H-UVzCer4YX5Uj8Q1QE5Z1
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTALLINE+FORMS+OF+2-%284-%284-ETHOXY-6-OXO-1%2C6-DIHYDROPYRIDIN-3-YL%29-2-FLUOROPHENYL%29-N-%285-%281%2C1%2C1-TRIFLUORO-2-METHYLPROPAN-2-YL%29ISOXAZOL-3-YL%29ACETAMIDE&rft.inventor=EIDAM%2C+HILARY+SCHENCK&rft.inventor=LAMEY%2C+KIMBERLY+ANNE&rft.inventor=THOMAS%2C+JAMES+V&rft.inventor=CHEUNG%2C+MUI&rft.inventor=CLARK%2C+WILLIAM+M&rft.date=2016-03-17&rft.externalDBID=A1&rft.externalDocID=CA2960451A1